M&A and equity raisings
6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
US deals dated after 30 September 2026 are still being collected.
93 deals · US$49bndisclosed · Medtech · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Apr 2026 | Avanos Medical | – | AIP | Acquisition | Completed | 1,272.0 | Medtech | J.P. Morgan (sell-side)Alston & Bird (sell-side)UBS (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Sidley Austin (buy-side)Ropes & Gray (buy-side)Baker Botts (buy-side)Guggenheim Securities (buy-side) |
| Apr 2026 | Bentec Medical | Greyrock Capital Group | Avista Healthcare Partners | Acquisition | Completed | – | Medtech+1 | Piper Sandler (sell-side)McGuireWoods (sell-side)Willkie Farr & Gallagher (buy-side) |
| Apr 2026 | View Point Medical | – | Merit Medical Systems | Acquisition | Completed | 140.0 | Medtech+1 | Piper Sandler (buy-side)Baker McKenzie (buy-side) |
| Apr 2026 | Midwest Products & Engineering | – | Graham Partners | Acquisition | Completed | – | Medtech+1 | Kirkland & Ellis (sell-side)Baird (sell-side)Dechert (buy-side) |
| Apr 2026 | Surgistar | – | Halma | Acquisition | Completed | – | Medtech | Baird (sell-side) |
| Apr 2026 | Amplitude Vascular Systems | – | Stryker | Acquisition | Completed | 835.0 | Medtech+1 | Perella Weinberg Partners (sell-side) |
| Mar 2026 | Owen Mumford Holdings | – | Embecta Corp. | Acquisition | Pending | 132.2 | Medtech+1 | Forvis Mazars (South Africa) (sell-side)Mills & Reeve (sell-side)J.P. Morgan (buy-side)A&O Shearman (buy-side) |
| Mar 2026 | Smartbox | CareTech Group | Verdane | Acquisition | Completed | – | Medtech+1 | William BlairSidley Austin (buy-side) |
| Mar 2026 | Scientia Vascular | – | Medtronic | Acquisition | Announced | 550.0 | Medtech+1 | Latham & Watkins (sell-side) |
| Feb 2026 | SDI | Jeffery James Cheetham | Beijing Guoci Kebo Technology Co. | Scheme | Completed | 118.2 | Medtech | Houlihan Lokey (sell-side)DLA Piper (sell-side)Rothschild & Co (buy-side)Herbert Smith Freehills Kramer (buy-side) |
| Feb 2026 | Precision NeuroMed | – | Brainlab SE | Stake | Completed | – | Biotech+2 | Sidley Austin (sell-side) |
| Feb 2026 | Uromedica | – | Coloplast A/S | Acquisition | Announced | – | Medtech | Davis Polk (buy-side) |
| Feb 2026 | Masimo | – | Danaher | Acquisition | Announced | 9,900.0 | Medtech+1 | McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side) |
| Feb 2026 | LKC Technologies | DW Healthcare Partners | AMETEK | Acquisition | Announced | – | Medtech+2 | William Blair (sell-side) |
| Feb 2026 | SAVI Surgical | – | Smartways Logistics | Acquisition | Completed | – | Medtech | Record Point (sell-side) |
| Feb 2026 | Auditdata | – | Undisclosed Buyer | Acquisition | Completed | – | Healthcare Software+1 | William Blair |
| Feb 2026 | Compass Health Brands | – | Drive Medical | Acquisition | Announced | – | Consumer Health+2 | Capstone Partners (sell-side) |
| Feb 2026 | Rayner | CVC Capital Partners VIII | Groupe Bruxelles Lambert | Stake | Announced | 588.6 | Medtech+1 | Latham & Watkins (sell-side)Kirkland & Ellis (buy-side) |
| Feb 2026 | DentalMonitoring | – | Lazard Elaia Capital | Stake | Announced | 100.0 | Medtech+2 | Latham & Watkins (buy-side) |
| Feb 2026 | Southern Cross Diagnostics | – | Novacyt SA | Acquisition | Completed | – | Medtech | Hamilton Locke (buy-side)Addleshaw Goddard (buy-side)Frieh, Brault & Associés (buy-side) |
| Jan 2026 | ArcRev | – | Symmetry Laser | Acquisition | Completed | – | Contract Manufacturing+1 | Covington & Burling |
| Jan 2026 | Resolution Medical | Arcline Investment Management | Resonetics | Acquisition | Announced | – | Medtech+1 | Piper Sandler (sell-side)Bass, Berry & Sims (sell-side)Fredrikson & Byron (sell-side)Nelson Mullins Riley & Scarborough (buy-side) |
| Jan 2026 | BioTissue non-ocular Surgical and Wound Care business | BioTissue Holdings | BioStem Technologies | Asset sale | Completed | – | Medtech | Bass, Berry & Sims (sell-side) |
| Jan 2026 | Penumbra | – | Boston Scientific | Acquisition | Announced | 14,500.0 | Medtech | Perella Weinberg Partners (sell-side)Davis Polk (sell-side)A&O Shearman (buy-side)Arnold & Porter (buy-side) |
| Jan 2026 | Integrity Orthopaedics | – | Smith+Nephew | Acquisition | Announced | 225.0 | Medtech | Sidley Austin (buy-side) |
| Jan 2026 | Conformal Medical | – | W. L. Gore & Associates | Acquisition | Announced | – | Medtech+1 | Davis Polk (buy-side) |
| Jan 2026 | Valencia Technologies | – | Boston Scientific | Acquisition | Announced | – | Medtech | Latham & Watkins (buy-side) |
| Jan 2026 | ACH Solution | – | IGS GeboJagema | Acquisition | Announced | – | Manufacturing+2 | Kirkland & Ellis (buy-side) |
| Jan 2026 | FRP medical device operations | FRP | IGS GeboJagema | Asset sale | Announced | – | Medtech+1 | Kirkland & Ellis (buy-side) |
| Jan 2026 | Medical Manufacturing Technologies (MMT) | – | Perimeter Solutions | Acquisition | Completed | 685.0 | Medtech+1 | William BlairBaird (buy-side) |
| Jan 2026 | Orchid Orthopedic Solutions | – | – | Merger | Announced | – | Medtech+2 | Kirkland & Ellis |
| Jan 2026 | Burlington Medical | Peninsula Capital Partners | TIDI Products | Acquisition | Completed | – | Medtech | Baird (sell-side) |
| 2026 | Technipaq | – | Nelipak Healthcare Packaging | Acquisition | Announced | – | Packaging+1 | Lincoln International (sell-side) |
| 2026 | Hallmarq Veterinary Imaging | – | NORD Holding | Acquisition | Announced | – | Animal Health+1 | Lincoln International (buy-side) |
| 2026 | Sidam Group | Mindful Capital Partners | Plastiflex Group | Acquisition | Announced | – | Medtech+1 | Lincoln International (sell-side) |
| 2026 | ChoiceSpine | Altus Capital Partners | Zavation | Acquisition | Announced | – | Medtech | Lincoln International (sell-side) |
| Dec 2025 | FONAR | – | Timothy R. Damadian | Acquisition | Announced | – | Medtech+2 | Marshall & Stevens (sell-side)DLA Piper (sell-side) |
| Dec 2025 | Quipt Home Medical Corp. | – | 1567208 B.C. | Scheme | Completed | – | Healthcare Services+1 | Evans & Evans (sell-side)Truist Securities (sell-side)DLA Piper (sell-side)McDermott Will & Schulte (buy-side)Fasken (buy-side)UBS (buy-side) |
| Sep 2025 | Solventum purification and filtration (P&F) business | Solventum Corp | Thermo Fisher Scientific | Asset sale | Announced | 4,000.0 | Medtech | Clayton Utz (sell-side)Cleary Gottlieb Steen & Hamilton (sell-side) |
| Jul 2025 | Bluechiip Limited (ASX:BCT) and its US-based subsidiary, the Bluechiip Group | – | Cryonix | Asset sale | Announced | – | Medtech | Moray & Agnew (sell-side)Mills Oakley (buy-side) |
| Jul 2025 | Invacare Holdings S.à r.l. and certain affiliates | Invacare | investment vehicles affiliated with Rhône Capital L.L.C. | Acquisition | Completed | – | Medtech | |
| Jun 2025 | Lyrebird Health | – | – | Stake | Completed | – | Medtech | Herbert Smith Freehills Kramer (sell-side)Corrs Chambers Westgarth (sell-side) |
| Aug 2024 | Evolution Surgical | – | Quadrant Private Equity | Stake | Announced | – | Medtech | Herbert Smith Freehills Kramer (buy-side)Boston Consulting Group (buy-side)KPMG (buy-side)GreenMount (buy-side) |
Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.